NRSN · Forms 3, 4, 5
Insider trades at NeuroSense Therapeutics Ltd.
No open-market insider buys or sells at NeuroSense Therapeutics Ltd. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for NeuroSense Therapeutics Ltd. (NRSN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for NeuroSense Therapeutics Ltd. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Alon Ben-Noon | Chief Executive Officer | Buy | 250,000 | $0.80 | $200K | Form 4 | |
| Or Eisenberg | Chief Financial Officer | Buy | 250,000 | $0.80 | $200K | Form 4 | |
| Or Eisenberg | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Revital Mandil-Levin | Director | Became an insider (Form 3) | Form 3 | ||||
| Niva Russek-Blum | Chief Technology Officer | Became an insider (Form 3) | Form 3 | ||||
| Alon Ben-Noon | Chief Executive Officer | Became an insider (Form 3) | Form 3 | ||||
| Or Eisenberg | Chief Financial Officer | Award | 200,000 | Form 4 | |||
| Niva Russek-Blum | Chief Technology Officer | Award | 200,000 | Form 4 | |||
| Hagit Binder | General Manager | Award | 200,000 | Form 4 | |||
| Christine A Pellizzari | Director | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.